Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized placebo controlled phase I/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C.
Veldt BJ, van der Vliet HJ, von Blomberg BM, van Vlierberghe H, Gerken G, Nishi N, Hayashi K, Scheper RJ, de Knegt RJ, van den Eertwegh AJ, Janssen HL, van Nieuwkerk CM. Veldt BJ, et al. Among authors: van vlierberghe h, van der vliet hj, van den eertwegh aj, van nieuwkerk cm. J Hepatol. 2007 Sep;47(3):356-65. doi: 10.1016/j.jhep.2007.04.018. Epub 2007 Jun 6. J Hepatol. 2007. PMID: 17599630 Clinical Trial.
A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.
Giaccone G, Punt CJ, Ando Y, Ruijter R, Nishi N, Peters M, von Blomberg BM, Scheper RJ, van der Vliet HJ, van den Eertwegh AJ, Roelvink M, Beijnen J, Zwierzina H, Pinedo HM. Giaccone G, et al. Among authors: van der vliet hj, van den eertwegh aj. Clin Cancer Res. 2002 Dec;8(12):3702-9. Clin Cancer Res. 2002. PMID: 12473579 Clinical Trial.
Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells.
van der Vliet HJ, Molling JW, Nishi N, Masterson AJ, Kölgen W, Porcelli SA, van den Eertwegh AJ, von Blomberg BM, Pinedo HM, Giaccone G, Scheper RJ. van der Vliet HJ, et al. Among authors: van den eertwegh aj. Cancer Res. 2003 Jul 15;63(14):4101-6. Cancer Res. 2003. PMID: 12874013
Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients.
van der Vliet HJ, Molling JW, von Blomberg BM, Kölgen W, Stam AG, de Gruijl TD, Mulder CJ, Janssen HL, Nishi N, van den Eertwegh AJ, Scheper RJ, van Nieuwkerk CJ. van der Vliet HJ, et al. Among authors: van nieuwkerk cj, van den eertwegh aj. Clin Immunol. 2005 Feb;114(2):183-9. doi: 10.1016/j.clim.2004.10.001. Clin Immunol. 2005. PMID: 15639652
Attenuation of invariant natural killer T-cell anergy induction through intradermal delivery of alpha-galactosylceramide.
Bontkes HJ, Moreno M, Hangalapura B, Lindenberg JJ, de Groot J, Lougheed S, van der Vliet HJ, van den Eertwegh AJ, de Gruijl TD, von Blomberg BM, Scheper RJ. Bontkes HJ, et al. Among authors: van der vliet hj, van den eertwegh aj. Clin Immunol. 2010 Sep;136(3):364-74. doi: 10.1016/j.clim.2010.04.019. Epub 2010 Jun 8. Clin Immunol. 2010. PMID: 20570567
Natural Killer T cells.
van der Vliet HJ, Pinedo HM, von Blomberg BM, van den Eertwegh AJ, Scheper RJ, Giaccone G. van der Vliet HJ, et al. Among authors: van den eertwegh aj. Lancet Oncol. 2002 Sep;3(9):574. doi: 10.1016/s1470-2045(02)00850-1. Lancet Oncol. 2002. PMID: 12217795 No abstract available.
The immunoregulatory role of CD1d-restricted natural killer T cells in disease.
van der Vliet HJ, Molling JW, von Blomberg BM, Nishi N, Kölgen W, van den Eertwegh AJ, Pinedo HM, Giaccone G, Scheper RJ. van der Vliet HJ, et al. Among authors: van den eertwegh aj. Clin Immunol. 2004 Jul;112(1):8-23. doi: 10.1016/j.clim.2004.03.003. Clin Immunol. 2004. PMID: 15207777 Review.
Invariant natural killer T cells and immunotherapy of cancer.
Molling JW, Moreno M, van der Vliet HJ, van den Eertwegh AJ, Scheper RJ, von Blomberg BM, Bontkes HJ. Molling JW, et al. Among authors: van der vliet hj, van den eertwegh aj. Clin Immunol. 2008 Nov;129(2):182-94. doi: 10.1016/j.clim.2008.07.025. Epub 2008 Sep 9. Clin Immunol. 2008. PMID: 18783990 Free article. Review.
141 results